NOBBIO, LUCILLA
NOBBIO, LUCILLA
100009 - Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol
2006-01-01 Pareyson, D; Schenone, A; Fabrizi, Gm; Santoro, L; Padua, L; Quattrone, A; Vita, G; Gemignani, F; Visioli, F; Solari, A; Salsano, E; Scaioli, V; Ciano, C; Rimoldi, M; Lauria, G; Rizzetto, E; Camozzi, F; Grandis, M; Narciso, E; Nobbio, L; Benedetti, L; Rizzuto, N; Cavallaro, T; Bertolasi, L; Casano, A; Manganelli, F; Nolano, M; Pazzaglia, C; Valentino, P; Nisticò, R; Pirritano, D; Lucisano, A; Canino, M; Mazzeo, A; Aguennouz, M; Di Leo, R; Girlanda, P; Majorana, G; Ciranni, A; Lanzano, N; Brindani, F; Lettieri, C; Bogani, P; Hughes, Rac; Mancardi, Gl; Cavaletti, G; Galimberti, S; Radice, D; Calabrese, D; Ferrari, G.
A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism
2022-01-01 Veneri, F. A.; Prada, V.; Mastrangelo, R.; Ferri, C.; Nobbio, L.; Passalacqua, M.; Milanesi, M.; Bianchi, F.; Del Carro, U.; Vallat, J. -M.; Duong, P.; Svaren, J.; Schenone, A.; Grandis, M.; D'Antonio, M.
A P2X7 antagonist improves muscle strength and motor distal amplitude in CMT1A rats: preliminary results from an in vivo trial.
2014-01-01 Sociali, Giovanna; Prukop, Thomas; Cervellini, Ilaria; Nobbio, Lucilla; Bruzzone, Santina; Schenone, Angelo; Sereda, Michael W.
Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22
2003-01-01 Chies, R; Nobbio, Lucilla; Edomi, P; Schenone, Angelo; Schneider, C; AND BRANCOLINI, C.
Alternative Splicing in the Human PMP22 Gene: Implications in CMT1A Neuropathy
2015-01-01 Visigalli, Davide; Castagnola, Patrizio; Capodivento, Giovanna; Geroldi, Alessandro; Bellone, Emilia; Mancardi, Gianluigi; Pareyson, Davide; Schenone, Angelo; Nobbio, Lucilla
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial.
2011-01-01 Pareyson, D; Reilly, Mm; Schenone, A; Fabrizi, Gm; Cavallaro, T; Manganelli, L; Vita, G; Quattrone, A; Padua, L; Gemignani, F; Visioli, F; Laurà, M; Radice, D; Calabrese, D; Hughes, Rac; Solari, A; Salsano, C; Nanetti, L; Marelli, C; Scaioli, V; Ciano, C; Rimoldi, M; Lauria, G; Rizzetto, E; Camozzi, F; Narciso, E; Grandis, M; Montibragadin, M; Nobbio, L; Casano, A; Bertolasi, L; Cabrini, I; Corrà, K; Rizzuto, N; Pisciotta, C; Nolano, M; Mazzeo, A; Aguennouz, M; Di Leo, R; Majorana, G; Lanzano, N; Valenti, F; Valentino, P; Nisticò, R; Pirritano, D; Lucisano, A; Canino, M; Pazzaglia, C; Granata, G; Foschini, M; Brindani, F; Vitetta, F; Allegri, I; Bogani, P; Blake, J; Koltzenburg, M; Hutton, E; Lunn, M; Cavaletti, G; Galimberti, S; Ferrari, G; Manganelli, F; Sereda, M.
Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease
2006-01-01 Nobbio, Lucilla; Gherardi, Gianfranco; Vigo, Tiziana; Passalacqua, Mario; Melloni, Edon; Abbruzzese, Michele; Mancardi, GIOVANNI LUIGI; Nave, K. A.; Schenone, Angelo
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS
2021-01-01 Capodivento, Giovanna; De Michelis, Chiara; Carpo, Marinella; Fancellu, Roberto; Schirinzi, Erika; Severi, Daniele; Visigalli, Davide; Franciotta, Diego; Manganelli, Fiore; Siciliano, Gabriele; Beronio, Alessandro; Capello, Elisabetta; Lanteri, Paola; Nobile-Orazio, Eduardo; Schenone, Angelo; Benedetti, Luana; Nobbio, Lucilla
DEVELOPMENT AND VALIDATION OF A BIOMARKERS PANEL TO CAPTURE PATHOPHYSIOLOGICAL HETEROGENEITY OF GBS AND CIDP PATIENTS
2023-01-01 Capodivento, G; Visigalli, D; Castellano, C; Germano, F; Garnero, M; Cabona, C; Marinelli, L; Beronio, A; Fancellu, R; Manganelli, F; Carpo, M; Siciliano, G; Nobile-Orazio, E; Franciotta, D; Benedetti, L; Schenone, A; Nobbio, L
Diadenosine homodinucleotide products of ADP-ribosyl cyclases behave as modulators of the purinergic receptor P2X7.
2010-01-01 Bruzzone, Santina; Basile, Giovanna; PARAKKOTTIL CHOTHI, M; Nobbio, Lucilla; Usai, C; Jacchetti, E; Schenone, Angelo; Guse, A. H.; DI VIRGILIO, F; DE FLORA, Antonio; Zocchi, Elena
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations
2008-01-01 Grandis, Marina; Vigo, Tiziana; Passalacqua, Mario; Jain, M; Scazzola, S; LA PADULA, V; Brucal, M; Benvenuto, F; Nobbio, Lucilla; Cadoni, Angela; Mancardi, GIOVANNI LUIGI; Kamholz, J; Shy, Me; Schenone, Angelo
Does parkin play a role in the peripheral nervous system? A family report
2004-01-01 Abbruzzese, Giovanni; Pigullo, S.; Schenone, Angelo; Bellone, Emilia; Marchese, R.; DI MARIA, Emilio; Benedetti, L.; Ciotti, P.; Nobbio, Lucilla; Bonifati, V.; Ajmar, Franco; Mandich, Paola
Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease.
2004-01-01 Grandis, Marina; Leandri, Massimo; Vigo, Tiziana; Cilli, M; Sereda, Mw; Gherardi, G; Benedetti, L; Mancardi, GIOVANNI LUIGI; Abbruzzese, Michele; Nave, Ka; Nobbio, Lucilla; Schenone, Angelo
Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats
1999-01-01 Tredici, Giovanni; Braga, Massimiliano; Nicolini, Gabriella; Miloso, Mariarosaria; Marmiroli, Paola; Schenone, Angelo; Nobbio, Lucilla; Frattola, Lodovico; Cavaletti, Guido
Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis
2005-01-01 Vigo, Tiziana; Nobbio, Lucilla; Hummelen, Pv; Abbruzzese, Michele; Mancardi, GIOVANNI LUIGI; Verpoorten, N; Verhoeven, K; Sereda, Mw; Nave, Ka; Timmerman, V; Schenone, Angelo
Genetic Workup for Charcot–Marie–Tooth Neuropathy: A Retrospective Single-Site Experience Covering 15 Years
2022-01-01 Gemelli, C.; Geroldi, A.; Massucco, S.; Trevisan, L.; Callegari, I.; Marinelli, L.; Ursino, G.; Hamedani, M.; Mennella, G.; Stara, S.; Maggi, G.; Mori, L.; Schenone, C.; Gotta, F.; Patrone, S.; Mammi, A.; Origone, P.; Prada, V.; Nobbio, L.; Mandich, P.; Schenone, A.; Bellone, E.; Grandis, M.
Guillain barré syndrome of axonal type in a multple sclerosis patient: Fortuitous association or linked disorders?
1997-01-01 Roccatagliata, L.; Capello, E.; Schenone, A.; Inglese, M.; Nobbio, L.; Grandis, M.; Maritato, F.; Abbruzzese, M.; Mancardi, G. L.
Hyccin, the Molecule Mutated in the Leukodystrophy Hypomyelination and Congenital Cataract (HCC), Is a Neuronal Protein.
2012-01-01 Gazzerro, E; Baldassari, Simona; Giacomini, C; Musante, V; Fruscione, Floriana; La Padula, V; Biancheri, R; Scarfi', Sonia; Prada, V; Sotgia, F; Duncan, Id; Zara, F; Werner, Hb; Lisanti, Mp; Nobbio, Lucilla; Corradi, ANNA MARGHERITA; Minetti, Carlo
Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy
2009-01-01 Nobbio, Lucilla; Fiorese, F; Vigo, Tiziana; Cilli, M; Gherardi, G; Grandis, Marina; Melcangi, Rc; Mancardi, GIOVANNI LUIGI; Abbruzzese, Michele; Schenone, Angelo
Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
2004-01-01 Nobbio, Lucilla; Vigo, T; Abbruzzese, Michele; Levi, G; Brancolini, C; Mantero, S; Grandis, Marina; Benedetti, L; Mancardi, GIOVANNI LUIGI; Schenone, Angelo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol | 1-gen-2006 | Pareyson, D; Schenone, A; Fabrizi, Gm; Santoro, L; Padua, L; Quattrone, A; Vita, G; Gemignani, F; Visioli, F; Solari, A; Salsano, E; Scaioli, V; Ciano, C; Rimoldi, M; Lauria, G; Rizzetto, E; Camozzi, F; Grandis, M; Narciso, E; Nobbio, L; Benedetti, L; Rizzuto, N; Cavallaro, T; Bertolasi, L; Casano, A; Manganelli, F; Nolano, M; Pazzaglia, C; Valentino, P; Nisticò, R; Pirritano, D; Lucisano, A; Canino, M; Mazzeo, A; Aguennouz, M; Di Leo, R; Girlanda, P; Majorana, G; Ciranni, A; Lanzano, N; Brindani, F; Lettieri, C; Bogani, P; Hughes, Rac; Mancardi, Gl; Cavaletti, G; Galimberti, S; Radice, D; Calabrese, D; Ferrari, G. | |
| A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism | 1-gen-2022 | Veneri, F. A.; Prada, V.; Mastrangelo, R.; Ferri, C.; Nobbio, L.; Passalacqua, M.; Milanesi, M.; Bianchi, F.; Del Carro, U.; Vallat, J. -M.; Duong, P.; Svaren, J.; Schenone, A.; Grandis, M.; D'Antonio, M. | |
| A P2X7 antagonist improves muscle strength and motor distal amplitude in CMT1A rats: preliminary results from an in vivo trial. | 1-gen-2014 | Sociali, Giovanna; Prukop, Thomas; Cervellini, Ilaria; Nobbio, Lucilla; Bruzzone, Santina; Schenone, Angelo; Sereda, Michael W. | |
| Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22 | 1-gen-2003 | Chies, R; Nobbio, Lucilla; Edomi, P; Schenone, Angelo; Schneider, C; AND BRANCOLINI, C. | |
| Alternative Splicing in the Human PMP22 Gene: Implications in CMT1A Neuropathy | 1-gen-2015 | Visigalli, Davide; Castagnola, Patrizio; Capodivento, Giovanna; Geroldi, Alessandro; Bellone, Emilia; Mancardi, Gianluigi; Pareyson, Davide; Schenone, Angelo; Nobbio, Lucilla | |
| Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. | 1-gen-2011 | Pareyson, D; Reilly, Mm; Schenone, A; Fabrizi, Gm; Cavallaro, T; Manganelli, L; Vita, G; Quattrone, A; Padua, L; Gemignani, F; Visioli, F; Laurà, M; Radice, D; Calabrese, D; Hughes, Rac; Solari, A; Salsano, C; Nanetti, L; Marelli, C; Scaioli, V; Ciano, C; Rimoldi, M; Lauria, G; Rizzetto, E; Camozzi, F; Narciso, E; Grandis, M; Montibragadin, M; Nobbio, L; Casano, A; Bertolasi, L; Cabrini, I; Corrà, K; Rizzuto, N; Pisciotta, C; Nolano, M; Mazzeo, A; Aguennouz, M; Di Leo, R; Majorana, G; Lanzano, N; Valenti, F; Valentino, P; Nisticò, R; Pirritano, D; Lucisano, A; Canino, M; Pazzaglia, C; Granata, G; Foschini, M; Brindani, F; Vitetta, F; Allegri, I; Bogani, P; Blake, J; Koltzenburg, M; Hutton, E; Lunn, M; Cavaletti, G; Galimberti, S; Ferrari, G; Manganelli, F; Sereda, M. | |
| Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease | 1-gen-2006 | Nobbio, Lucilla; Gherardi, Gianfranco; Vigo, Tiziana; Passalacqua, Mario; Melloni, Edon; Abbruzzese, Michele; Mancardi, GIOVANNI LUIGI; Nave, K. A.; Schenone, Angelo | |
| CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS | 1-gen-2021 | Capodivento, Giovanna; De Michelis, Chiara; Carpo, Marinella; Fancellu, Roberto; Schirinzi, Erika; Severi, Daniele; Visigalli, Davide; Franciotta, Diego; Manganelli, Fiore; Siciliano, Gabriele; Beronio, Alessandro; Capello, Elisabetta; Lanteri, Paola; Nobile-Orazio, Eduardo; Schenone, Angelo; Benedetti, Luana; Nobbio, Lucilla | |
| DEVELOPMENT AND VALIDATION OF A BIOMARKERS PANEL TO CAPTURE PATHOPHYSIOLOGICAL HETEROGENEITY OF GBS AND CIDP PATIENTS | 1-gen-2023 | Capodivento, G; Visigalli, D; Castellano, C; Germano, F; Garnero, M; Cabona, C; Marinelli, L; Beronio, A; Fancellu, R; Manganelli, F; Carpo, M; Siciliano, G; Nobile-Orazio, E; Franciotta, D; Benedetti, L; Schenone, A; Nobbio, L | |
| Diadenosine homodinucleotide products of ADP-ribosyl cyclases behave as modulators of the purinergic receptor P2X7. | 1-gen-2010 | Bruzzone, Santina; Basile, Giovanna; PARAKKOTTIL CHOTHI, M; Nobbio, Lucilla; Usai, C; Jacchetti, E; Schenone, Angelo; Guse, A. H.; DI VIRGILIO, F; DE FLORA, Antonio; Zocchi, Elena | |
| Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations | 1-gen-2008 | Grandis, Marina; Vigo, Tiziana; Passalacqua, Mario; Jain, M; Scazzola, S; LA PADULA, V; Brucal, M; Benvenuto, F; Nobbio, Lucilla; Cadoni, Angela; Mancardi, GIOVANNI LUIGI; Kamholz, J; Shy, Me; Schenone, Angelo | |
| Does parkin play a role in the peripheral nervous system? A family report | 1-gen-2004 | Abbruzzese, Giovanni; Pigullo, S.; Schenone, Angelo; Bellone, Emilia; Marchese, R.; DI MARIA, Emilio; Benedetti, L.; Ciotti, P.; Nobbio, Lucilla; Bonifati, V.; Ajmar, Franco; Mandich, Paola | |
| Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease. | 1-gen-2004 | Grandis, Marina; Leandri, Massimo; Vigo, Tiziana; Cilli, M; Sereda, Mw; Gherardi, G; Benedetti, L; Mancardi, GIOVANNI LUIGI; Abbruzzese, Michele; Nave, Ka; Nobbio, Lucilla; Schenone, Angelo | |
| Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats | 1-gen-1999 | Tredici, Giovanni; Braga, Massimiliano; Nicolini, Gabriella; Miloso, Mariarosaria; Marmiroli, Paola; Schenone, Angelo; Nobbio, Lucilla; Frattola, Lodovico; Cavaletti, Guido | |
| Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis | 1-gen-2005 | Vigo, Tiziana; Nobbio, Lucilla; Hummelen, Pv; Abbruzzese, Michele; Mancardi, GIOVANNI LUIGI; Verpoorten, N; Verhoeven, K; Sereda, Mw; Nave, Ka; Timmerman, V; Schenone, Angelo | |
| Genetic Workup for Charcot–Marie–Tooth Neuropathy: A Retrospective Single-Site Experience Covering 15 Years | 1-gen-2022 | Gemelli, C.; Geroldi, A.; Massucco, S.; Trevisan, L.; Callegari, I.; Marinelli, L.; Ursino, G.; Hamedani, M.; Mennella, G.; Stara, S.; Maggi, G.; Mori, L.; Schenone, C.; Gotta, F.; Patrone, S.; Mammi, A.; Origone, P.; Prada, V.; Nobbio, L.; Mandich, P.; Schenone, A.; Bellone, E.; Grandis, M. | |
| Guillain barré syndrome of axonal type in a multple sclerosis patient: Fortuitous association or linked disorders? | 1-gen-1997 | Roccatagliata, L.; Capello, E.; Schenone, A.; Inglese, M.; Nobbio, L.; Grandis, M.; Maritato, F.; Abbruzzese, M.; Mancardi, G. L. | |
| Hyccin, the Molecule Mutated in the Leukodystrophy Hypomyelination and Congenital Cataract (HCC), Is a Neuronal Protein. | 1-gen-2012 | Gazzerro, E; Baldassari, Simona; Giacomini, C; Musante, V; Fruscione, Floriana; La Padula, V; Biancheri, R; Scarfi', Sonia; Prada, V; Sotgia, F; Duncan, Id; Zara, F; Werner, Hb; Lisanti, Mp; Nobbio, Lucilla; Corradi, ANNA MARGHERITA; Minetti, Carlo | |
| Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy | 1-gen-2009 | Nobbio, Lucilla; Fiorese, F; Vigo, Tiziana; Cilli, M; Gherardi, G; Grandis, Marina; Melcangi, Rc; Mancardi, GIOVANNI LUIGI; Abbruzzese, Michele; Schenone, Angelo | |
| Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease. | 1-gen-2004 | Nobbio, Lucilla; Vigo, T; Abbruzzese, Michele; Levi, G; Brancolini, C; Mantero, S; Grandis, Marina; Benedetti, L; Mancardi, GIOVANNI LUIGI; Schenone, Angelo |